Who owns NOVOCURE LIMITED?

Tip: Access positions for across all investors

Analyze quarterly positions in Novocure with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Novocure stock

Who bought or sold NOVOCURE LIMITED this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Braidwell 136M $125M 0% Mar 2024
 View chart
Tenor Capital Management 91M $83B 0% Mar 2024
 View chart
Opti Capital Management 73M $67M 3% Mar 2024
 View chart
DeepCurrents Investment Group 47M $43M 4% Mar 2024
 View chart
Steelhead Partners 33M $30B -7% Mar 2024
 View chart
Balyasny Asset Management 27M $24M 6% Mar 2024
 View chart
Verition Fund Management 18M $17M 99900% Mar 2024
 View chart
Point72 Asset Management 10M $9.1M 25% Mar 2024
 View chart
Capstone Investment Advisors 5.3M $4.8M 0% Mar 2024
 View chart
Kohlberg Kravis Roberts & Co 4.6M $4.2M 52% Mar 2024
 View chart
Bnp Paribas Investment Partners 3.0M $2.7M 0% Mar 2024
 View chart
Jpmorgan Chase & Co 3.0M $2.7M -28% Mar 2024
 View chart
Shenkman Capital Management 1.8M $1.6B -57% Mar 2024
 View chart
Wells Fargo & Company 1.3M $1.2M -56% Mar 2024
 View chart
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.0M $904k 0% Mar 2024
 View chart
Palisade Capital Management 992k $903k 0% Mar 2024
 View chart
Zazove Associates 158k $144k 0% Mar 2024
 View chart
Leucadia National Corporation 110k $100k 100% Mar 2024
 View chart
Barclays 100k $90k 400% Mar 2024
 View chart

Who sold out of Novocure?

Fund or Company Name Date Sold Shares Held Valued At
Linden Advisors Sep 2023 42M $36B